✦ LIBER ✦

Does BCR-ABL genomic rearrangement persist in CML patients in complete remission after interferon α therapy?

✍ Scribed by Brizard, F; Chomel, J C; Veinstein, A; Rivet, J; Giraud, C; Kitzis, A; Guilhot, F; Brizard, A

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Variable numbers of BCR-ABL transcripts

✍ A. Hochhaus; F. Lin; A. Reiter; H. Skladny; F. van Rhee; P. C. A. Shepherd; N. C 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 490 KB

Quantification of BCR-ABL transcripts in

✍ Martinelli, G; Testoni, N; Amabile, M; Bonifazi, F; De Vivo, A; Farabegoli, P; T 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 72 KB

Do transcriptionally silent BCR-ABL cell

✍ Moravcová, J; Nádvorníkova, S; Sieglová, Z; Formánková, R; Krsková, L; Dvořáková 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 82 KB

Early reduction of BCR-ABL mRNA transcri

✍ Merx, K; Müller, M C; Kreil, S; Lahaye, T; Paschka, P; Schoch, C; Weisser, A; Ku 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 147 KB

Early prediction of molecular remission

✍ Yoo-Jin Kim; Dong-Wook Kim; Seok Lee; Chang-Ki Min; Hyun-Gyung Goh; Su-Hyun Kim; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 154 KB

804 Dasatinib Combined with Interferon-α

✍ A. Megan Cornelison; Charles Koller; Elias Jabbour 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 184 KB